Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03435679
Other study ID # MLL_02_2018
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date March 1, 2027

Study information

Verified date April 2024
Source Odense University Hospital
Contact Martin Lindberg-Larsen, MD, PhD
Phone 0045 25213900
Email martin.lindberg-larsen@rsyd.dk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study investigates functional outcome and safety after one-stage versus two-stage revision of the infected knee arthroplasty. Half of participants are treated with a one-stage surgical procedure, while the other half is treated with a two-stage procedure. The investigators hypothesize that the functional outcome and quality of life of the participants is superior after one-stage surgery compared to two-stage surgery.


Description:

A two-stage approach is the standard surgical procedure in the treatment of the chronically infected knee arthroplasty, but promising results have been reported after a one-stage approach from single-centre studies. The potential benefits for the patients treated with a one-stage approach are many as they only have to go through surgery and rehabilitation once with shorter total length of hospital stay. However, no randomized controlled trials comparing outcome after the procedures have been performed so far.


Recruitment information / eligibility

Status Recruiting
Enrollment 96
Est. completion date March 1, 2027
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Clinical signs of periprosthetic knee infection - > 6 weeks from previous knee arthoplasty procedure (primary or total revision procedure) - Speak and understand Danish and have given informed consent Exclusion Criteria: - Soft tissue problems requiring plastic surgery - major bone loss requiring mega/tumor-prosthesis - acute surgery due to sepsis - malignant disease with less than 2 years life expectancy - re-infection with previous two-stage procedure - bilateral knee infection

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
one-stage
one-stage surgery
two-stage
two-stage surgery

Locations

Country Name City State
Denmark Aalborg University Hospital Aalborg
Denmark Aarhus University Hospital Arhus
Denmark Bispebjerg Hospital Copenhagen
Denmark Gentofte Hospital Copenhagen
Denmark Hvidovre Hospital Copenhagen
Denmark Rigshospitalet Copenhagen
Denmark Horsens Hospital Horsens
Denmark Køge Hospital Køge
Denmark Næstved Hospital Næstved
Denmark Odense Universitets Hospital Odense
Denmark Silkeborg Hospital Silkeborg
Denmark Vejle Hospital Vejle

Sponsors (3)

Lead Sponsor Collaborator
Odense University Hospital Odense Patient Data Explorative Network, Region of Southern Denmark

Country where clinical trial is conducted

Denmark, 

References & Publications (7)

Baker P, Petheram TG, Kurtz S, Konttinen YT, Gregg P, Deehan D. Patient reported outcome measures after revision of the infected TKR: comparison of single versus two-stage revision. Knee Surg Sports Traumatol Arthrosc. 2013 Dec;21(12):2713-20. doi: 10.1007/s00167-012-2090-7. Epub 2012 Jun 13. — View Citation

Haddad FS, Sukeik M, Alazzawi S. Is single-stage revision according to a strict protocol effective in treatment of chronic knee arthroplasty infections? Clin Orthop Relat Res. 2015 Jan;473(1):8-14. doi: 10.1007/s11999-014-3721-8. — View Citation

Lindberg-Larsen M, Jorgensen CC, Bagger J, Schroder HM, Kehlet H. Revision of infected knee arthroplasties in Denmark. Acta Orthop. 2016 Aug;87(4):333-8. doi: 10.3109/17453674.2016.1148453. Epub 2016 Feb 22. — View Citation

Lindberg-Larsen M, Pitter FT, Voldstedlund M, Schroder HM, Bagger J. Microbiological diagnosis in revision of infected knee arthroplasties in Denmark. Infect Dis (Lond). 2017 Nov-Dec;49(11-12):824-830. doi: 10.1080/23744235.2017.1350878. Epub 2017 Jul 8. — View Citation

Massin P, Delory T, Lhotellier L, Pasquier G, Roche O, Cazenave A, Estellat C, Jenny JY. Infection recurrence factors in one- and two-stage total knee prosthesis exchanges. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3131-3139. doi: 10.1007/s00167-015-3884-1. Epub 2015 Nov 26. — View Citation

Masters JP, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord. 2013 Jul 29;14:222. doi: 10.1186/1471-2474-14-222. — View Citation

Singer J, Merz A, Frommelt L, Fink B. High rate of infection control with one-stage revision of septic knee prostheses excluding MRSA and MRSE. Clin Orthop Relat Res. 2012 May;470(5):1461-71. doi: 10.1007/s11999-011-2174-6. Epub 2011 Nov 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Oxford Knee Score (AUC) Area Under Curve for Oxford Knee Score preoperatively 6 weeks, 3, 6, 9, 12 months postoperatively.
Secondary Oxford Knee Score (AUC) Area Under Curve for Oxford Knee Score preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
Secondary EQ-5D-5L Quality of life questionnaire preoperatively, 6 weeks, 3, 6, 9, 12, 18 and 24 months postoperatively.
Secondary Re-revision rate re-revisions due to infection and other causes 2 year postoperatively
Secondary mortality postoperative mortality 90 days postoperatively and 1 and 2 year postoperatively
Secondary readmission rate postoperative readmission rate 90 days postoperatively
Secondary Range of Motion Range of motion of the infected/operated knee 2 years postoperatively
See also
  Status Clinical Trial Phase
Recruiting NCT04427943 - Outcome After Revisions of Infected Knee Arthroplasties